Abiopharma

News list

Director NIEKAMP CYNTHIA A 🟡 adjusted position in 2.9K shares (2 derivative) of BALL Corp (BALL) Transaction Date: Apr 29, 2026 | Filing ID: 000105

Full text

News bot May 1, 2026, 11:16 p.m.
🔍 NIEKAMP CYNTHIA A (Director)

Company: BALL Corp (BALL)

Report Date: 2026-04-29
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 2
- Holdings reported: 0
- Total shares acquired: 6,272
- Total shares sold: 3,369
Detailed Transactions and Holdings:
- Acquired 3,369 shares of Common Stock (Direct)
  Date: 2026-04-30 | Code: M | equity_swap_involved: 0 | shares_owned_after: 24,949.04 | transaction_form_type: 4 | Footnotes: F1, F2
- Acquired 2,903 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-29 | Code: A | equity_swap_involved: 0 | shares_owned_after: 32,216.00 | transaction_form_type: 4 | Footnotes: F3, F4, F5, F5
- Sold 3,369 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-30 | Code: M | equity_swap_involved: 0 | shares_owned_after: 28,847.00 | transaction_form_type: 4 | Footnotes: F3, F1, F2, F6, F6
Footnotes:
- F1: Common stock acquired upon the lapse of Table II Restricted Stock Units.
- F2: N/A
- F3: Each restricted stock unit represents a contingent right to receive one share of Ball Corporation Common Stock.
- F4: Annual Restricted Stock Unit Award (RSU) granted to non-employee Directors under Ball Corporation's Stock and Cash Incentive Plan.
- F5: Restricted stock units vest on the first anniversary of the award date, subject generally to continued service during the term.
- F6: Lapse of restricted stock units.